129 related articles for article (PubMed ID: 941184)
1. Identification of (23S)-5beta-cholestane-3alpha, 7alpha, 12alpha, 23, 25-pentol in cerebrotendinous xanthomatosis.
Hoshita T; Yasuhara M; Kihira K; Kuramoto T
Steroids; 1976 May; 27(5):657-64. PubMed ID: 941184
[TBL] [Abstract][Full Text] [Related]
2. Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5beta-cholestane-3alpha, 7alpha, 12alpha, 24xi, 25-pentol and 5beta-cholestane-3alpha, 7alpha, 12alpha, 23xi, 25-pentol.
Shefer S; Dayal B; Tint GS; Salen G; Mosbach EH
J Lipid Res; 1975 Jul; 16(4):280-6. PubMed ID: 1141769
[TBL] [Abstract][Full Text] [Related]
3. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
4. New bile alcohols - synthesis of (22R)- and (22S)-5beta-cholestane-3alpha,7alpha,12alpha,22,25-pentols.
Kihira K; Kuramoto T; Hoshita T
Steroids; 1976 Mar; 27(3):383-93. PubMed ID: 1265799
[TBL] [Abstract][Full Text] [Related]
5. Anomalous enantioselectivity in the sharpless asymmetric dihydroxylation reaction of 24-nor-5beta-cholest-23-ene-3alpha,7alpha,12alpha-triol: synthesis of substrates for studies of cholesterol side-chain oxidation.
Ertel NH; Dayal B; Rao K; Salen G
Lipids; 1999 Apr; 34(4):395-405. PubMed ID: 10443973
[TBL] [Abstract][Full Text] [Related]
6. A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.
Shefer S; Cheng FW; Dayal B; Hauser S; Tint GS; Salen G; Mosbach EH
J Clin Invest; 1976 Apr; 57(4):897-903. PubMed ID: 181403
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of bile alcohols in the perfused rabbit liver.
Cohen BI; Kuramoto T; Rothschild MA; Mosbach EH
J Biol Chem; 1976 May; 251(9):2709-15. PubMed ID: 1262339
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 5beta-cholestane-3alpha, 7alpha, 12alpha, 25-tetrol and 5beta-cholestane-3alpha, 7alpha, 245, 25-pentol.
Dayal B; Shefer S; Tint GS; Salen G; Mosbach EH
J Lipid Res; 1976 Jan; 17(1):74-7. PubMed ID: 1255022
[TBL] [Abstract][Full Text] [Related]
9. Structural and biosynthetic studies of a principal bile alcohol, 27-nor-5beta-cholestane-3alpha,7alpha,12alpha,24,25-pentol, in human urine.
Une M; Takenaka S; Kuramoto T; Fujimura K; Hoshita T; Kihira K
J Lipid Res; 2000 Oct; 41(10):1562-7. PubMed ID: 11013297
[TBL] [Abstract][Full Text] [Related]
10. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
[TBL] [Abstract][Full Text] [Related]
11. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
[TBL] [Abstract][Full Text] [Related]
12. Absolute configuration of pentahydroxy bile alcohols excreted by patients with cerebrotendinous xanthomatosis: a circular dichroism study.
Dayal B; Salen G; Tint GS; Toome V; Shefer S; Mosbach EH
J Lipid Res; 1978 Feb; 19(2):187-90. PubMed ID: 632682
[TBL] [Abstract][Full Text] [Related]
13. Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid.
Salen G; Shefer S; Setoguchi T; Mosbach EH
J Clin Invest; 1975 Jul; 56(1):226-31. PubMed ID: 1141434
[TBL] [Abstract][Full Text] [Related]
14. Cholic acid biosynthesis: conversion of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol into 5beta-cholestane-3alpha,7alpha, 12alpha,24beta,25-pentol by human and rat liver microsomes.
Cheng FW; Shefer S; Dayal B; Tint GS; Setoguchi T; Salen G; Mosbach EH
J Lipid Res; 1977 Jan; 18(1):6-13. PubMed ID: 13134
[TBL] [Abstract][Full Text] [Related]
15. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Biol Chem; 2001 Sep; 276(37):34579-85. PubMed ID: 11454857
[TBL] [Abstract][Full Text] [Related]
16. C26-Analogs of naturally occurring C27 bile alcohols.
Dayal B; Shefer S; Tint GS; Salen G; Mosbach EH
J Lipid Res; 1976 Sep; 17(5):478-84. PubMed ID: 965840
[TBL] [Abstract][Full Text] [Related]
17. Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis.
Kihira K; Fukuda K; Kuramoto T; Kuriyama M; Fujiyama J; Osame M; Hoshita T
Steroids; 1991 Sep; 56(9):464-8. PubMed ID: 1805458
[TBL] [Abstract][Full Text] [Related]
18. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
[TBL] [Abstract][Full Text] [Related]
19. Isolation and Identification of a Urinary Biomarker for Lung Cancer: 27-Nor-5β-Cholestane-3α,7α,12α,24
Blackman B; Raju N; Mushti C; Lane K; Patel D; Harris C; Swenson RE
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930845
[TBL] [Abstract][Full Text] [Related]
20. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
Setoguchi T; Salen G; Tint GS; Mosbach EH
J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]